Investor Deadline Approaches
Law Offices of Howard G. Smith is reminding investors of an impending deadline in the ongoing class action lawsuit against Metagenomi, Inc. (MGX). Investors who purchased MGX securities during the Company’s February 2024 initial public offering (IPO) must file a lead plaintiff motion by November 25, 2024.
Collaboration Fallout
Metagenomi, which conducted its IPO on February 13, 2024, experienced a setback when its collaboration with Moderna came to an unexpected end. Less than three months after the IPO, on May 1, 2024, the termination of the collaboration was announced, leading to a sharp decline in Metagenomi’s stock price.
Allegations of Misconduct
The class action complaint alleges that throughout the Class Period, Defendants failed to disclose crucial information regarding Metagenomi’s business operations. Specifically, they did not reveal that the collaboration with Moderna would be terminated abruptly, leading to misleading statements about the Company’s prospects.
Legal Recourse
If investors purchased Metagenomi securities during the IPO period, they have the option to move the Court for lead plaintiff status by November 25, 2024. Investors can choose to engage legal counsel or remain passive members of the class action. For further information or inquiries about the class action, Howard G. Smith, Esquire, can be reached at the Law Offices of Howard G. Smith.
Disclaimer
Note: This press release may be considered Attorney Advertising in certain jurisdictions under applicable laws and ethical rules.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20241001320401/en/
